Free Trial
NYSE:A

Agilent Technologies Q2 2025 Earnings Report

Agilent Technologies logo
$106.46 -1.14 (-1.06%)
Closing price 05/1/2025 03:59 PM Eastern
Extended Trading
$107.41 +0.95 (+0.89%)
As of 05/1/2025 07:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Agilent Technologies EPS Results

Actual EPS
N/A
Consensus EPS
$1.27
Beat/Miss
N/A
One Year Ago EPS
N/A

Agilent Technologies Revenue Results

Actual Revenue
N/A
Expected Revenue
$1.63 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Agilent Technologies Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Wednesday, May 28, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

Agilent Technologies Earnings Headlines

The Preferred Stock IPO Market Is Frozen
Watch This Robotics Demo Before July 23rd
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."
See More Agilent Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Agilent Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Agilent Technologies and other key companies, straight to your email.

About Agilent Technologies

Agilent Technologies (NYSE:A) provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

View Agilent Technologies Profile

More Earnings Resources from MarketBeat